• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨膜衔接蛋白PAG1是神经母细胞瘤中的一种新型肿瘤抑制因子。

Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma.

作者信息

Agarwal Saurabh, Ghosh Rajib, Chen Zaowen, Lakoma Anna, Gunaratne Preethi H, Kim Eugene S, Shohet Jason M

机构信息

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, and Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas 77030, USA.

Department of Biology & Biochemistry, University of Houston, Houston, Texas 77204, USA.

出版信息

Oncotarget. 2016 Apr 26;7(17):24018-26. doi: 10.18632/oncotarget.8116.

DOI:10.18632/oncotarget.8116
PMID:26993602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5029681/
Abstract

Neuroblastoma (NB) is the most common extracranial pediatric solid tumor with high mortality rates. The tyrosine kinase c-Src has been known to play an important role in differentiation of NB cells, but the mechanism of c-Src regulation has not been defined. Here, we characterize PAG1 (Cbp, Csk binding protein), a central inhibitor of c-Src and other Src family kinases, as a novel tumor suppressor in NB. Clinical cohort analysis demonstrate that low expression of PAG1 is a significant prognostic factor for high stage disease, increased relapse, and worse overall survival for children with NB. PAG1 knockdown in NB cells promotes proliferation and anchorage-independent colony formation with increased activation of AKT and ERK downstream of c-Src, while PAG1 overexpression significantly rescues these effects. In vivo, PAG1 overexpression significantly inhibits NB tumorigenicity in an orthotopic xenograft model. Our results establish PAG1 as a potent tumor suppressor in NB by inhibiting c-Src and downstream effector pathways. Thus, reactivation of PAG1 and inhibition of c-Src kinase activity represents an important novel therapeutic approach for high-risk NB.

摘要

神经母细胞瘤(NB)是最常见的儿童颅外实体瘤,死亡率很高。已知酪氨酸激酶c-Src在NB细胞分化中起重要作用,但c-Src调控机制尚未明确。在此,我们将PAG1(Cbp,Csk结合蛋白),一种c-Src和其他Src家族激酶的核心抑制剂,鉴定为NB中的一种新型肿瘤抑制因子。临床队列分析表明,PAG1低表达是NB患儿疾病分期高、复发增加及总生存期较差的一个重要预后因素。NB细胞中PAG1敲低促进增殖和不依赖贴壁的集落形成,同时c-Src下游的AKT和ERK激活增加,而PAG1过表达显著逆转这些效应。在体内,PAG1过表达在原位异种移植模型中显著抑制NB致瘤性。我们的结果通过抑制c-Src及其下游效应通路将PAG1确立为NB中一种有效的肿瘤抑制因子。因此,重新激活PAG1并抑制c-Src激酶活性代表了一种针对高危NB的重要新型治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/ec3426257a1c/oncotarget-07-24018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/e8db1e9a4868/oncotarget-07-24018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/0dfd5cc45624/oncotarget-07-24018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/75e0cd1c1cf7/oncotarget-07-24018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/ff74513f6dc5/oncotarget-07-24018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/ec3426257a1c/oncotarget-07-24018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/e8db1e9a4868/oncotarget-07-24018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/0dfd5cc45624/oncotarget-07-24018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/75e0cd1c1cf7/oncotarget-07-24018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/ff74513f6dc5/oncotarget-07-24018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a135/5029681/ec3426257a1c/oncotarget-07-24018-g005.jpg

相似文献

1
Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma.跨膜衔接蛋白PAG1是神经母细胞瘤中的一种新型肿瘤抑制因子。
Oncotarget. 2016 Apr 26;7(17):24018-26. doi: 10.18632/oncotarget.8116.
2
The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.跨膜接头蛋白 Cbp/PAG1 控制着 c-src 上调的人类非小细胞肺癌的恶性潜能。
Mol Cancer Res. 2011 Jan;9(1):103-14. doi: 10.1158/1541-7786.MCR-10-0340. Epub 2010 Dec 14.
3
Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.新型Src/Abl酪氨酸激酶抑制剂博舒替尼通过抑制Src/Abl信号传导来抑制神经母细胞瘤的生长。
Oncotarget. 2017 Jan 3;8(1):1469-1480. doi: 10.18632/oncotarget.13643.
4
PAG1 directs SRC-family kinase intracellular localization to mediate receptor tyrosine kinase-induced differentiation.PAG1 指导 SRC 家族激酶的细胞内定位,以介导受体酪氨酸激酶诱导的分化。
Mol Biol Cell. 2020 Sep 15;31(20):2269-2282. doi: 10.1091/mbc.E20-02-0135. Epub 2020 Jul 29.
5
Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.肿瘤抑制因子 C 端Src 激酶(Csk)结合蛋白(Cbp)/PAG1 的下调是通过有丝分裂原活化蛋白激酶(MAPK)/磷酸肌醇 3-激酶(PI3K)通路介导的表观遗传组蛋白修饰来实现的。
J Biol Chem. 2011 May 6;286(18):15698-706. doi: 10.1074/jbc.M110.195362. Epub 2011 Mar 9.
6
[Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].[应用cDNA芯片筛选糖鞘脂微结构域相关磷蛋白1(PAG1)及PAG1过表达对人转移性前列腺癌细胞系体外生物学行为的影响]
Zhonghua Bing Li Xue Za Zhi. 2010 Feb;39(2):88-94.
7
Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.新型MDM2抑制剂SAR405838(MI-773)诱导神经母细胞瘤中p53介导的细胞凋亡。
Oncotarget. 2016 Dec 13;7(50):82757-82769. doi: 10.18632/oncotarget.12634.
8
Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancer.PAG1/Cbp的上调促进脂肪来源的间充质干细胞在乳腺癌中促进肿瘤进展和化疗耐药。
Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):719-727. doi: 10.1016/j.bbrc.2017.10.118. Epub 2017 Oct 24.
9
miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1.miR-205 通过靶向 cAMP 反应元件结合蛋白 1 抑制神经母细胞瘤生长。
Oncol Res. 2018 Apr 10;26(3):445-455. doi: 10.3727/096504017X14974834436195. Epub 2017 Jun 26.
10
NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.NSC-87877抑制神经母细胞瘤中DUSP26的功能,导致p53介导的细胞凋亡。
Cell Death Dis. 2015 Aug 6;6(8):e1841. doi: 10.1038/cddis.2015.207.

引用本文的文献

1
Transcriptomic profiling in canine B-cell lymphoma supports a synergistic effect of BTK and PI3K inhibitors.犬B细胞淋巴瘤的转录组分析支持布鲁顿酪氨酸激酶(BTK)和磷脂酰肌醇-3-激酶(PI3K)抑制剂的协同作用。
Front Vet Sci. 2025 Apr 25;12:1577028. doi: 10.3389/fvets.2025.1577028. eCollection 2025.
2
CSK-mediated signalling by integrins in cancer.整合素在癌症中由CSK介导的信号传导
Front Cell Dev Biol. 2023 Jul 7;11:1214787. doi: 10.3389/fcell.2023.1214787. eCollection 2023.
3
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation.

本文引用的文献

1
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.粒细胞集落刺激因子通过STAT3依赖性癌症干细胞激活促进神经母细胞瘤的致瘤性和转移。
Cancer Res. 2015 Jun 15;75(12):2566-79. doi: 10.1158/0008-5472.CAN-14-2946. Epub 2015 Apr 23.
2
MicroRNAs as the fine-tuners of Src oncogenic signalling.微小RNA作为Src致癌信号的微调器
J Biochem. 2015 Jun;157(6):431-8. doi: 10.1093/jb/mvv036. Epub 2015 Apr 9.
3
The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
血清微小RNA作为神经母细胞瘤负荷和治疗性p53重新激活生物标志物的纵向评估
NAR Cancer. 2023 Jan 18;5(1):zcad002. doi: 10.1093/narcan/zcad002. eCollection 2023 Mar.
4
Analysis of the Hypoxic Response in a Mouse Cortical Collecting Duct-Derived Cell Line Suggests That Esrra Is Partially Involved in Hif1α-Mediated Hypoxia-Inducible Gene Expression in mCCD Cells.分析小鼠皮质集合管衍生细胞系的低氧反应表明,Esrra 部分参与 mCCD 细胞中 Hif1α 介导的低氧诱导基因表达。
Int J Mol Sci. 2022 Jun 30;23(13):7262. doi: 10.3390/ijms23137262.
5
Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth.CUDC-907对PI3K和HDAC的双重靶向作用抑制小儿神经母细胞瘤生长。
Cancers (Basel). 2022 Feb 20;14(4):1067. doi: 10.3390/cancers14041067.
6
Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology.系统评价神经母细胞瘤病理生理学中的受体酪氨酸激酶超家族。
Cancer Metastasis Rev. 2022 Mar;41(1):33-52. doi: 10.1007/s10555-021-10001-7. Epub 2021 Oct 30.
7
PAG1 directs SRC-family kinase intracellular localization to mediate receptor tyrosine kinase-induced differentiation.PAG1 指导 SRC 家族激酶的细胞内定位,以介导受体酪氨酸激酶诱导的分化。
Mol Biol Cell. 2020 Sep 15;31(20):2269-2282. doi: 10.1091/mbc.E20-02-0135. Epub 2020 Jul 29.
8
Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.揭示 NF1-MPNST 中的肿瘤内异质性和克隆进化。
Genes (Basel). 2020 May 1;11(5):499. doi: 10.3390/genes11050499.
9
SLAMF6 clustering is required to augment T cell activation.SLAMF6 聚类是增强 T 细胞激活所必需的。
PLoS One. 2019 Jun 14;14(6):e0218109. doi: 10.1371/journal.pone.0218109. eCollection 2019.
10
Identification of Integrin β1 as a Novel PAG1-Interacting Protein Involved in the Inherent Radioresistance of Human Laryngeal Carcinoma.整合素β1作为一种新型PAG1相互作用蛋白的鉴定及其与人类喉癌固有放射抗性的关系
J Cancer. 2018 Oct 18;9(22):4128-4138. doi: 10.7150/jca.26885. eCollection 2018.
原癌基因c-Src及其下游信号通路受到转移抑制因子NDRG1的抑制。
Oncotarget. 2015 Apr 20;6(11):8851-74. doi: 10.18632/oncotarget.3316.
4
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.Src蛋白酪氨酸激酶的结构、作用机制及小分子抑制剂
Pharmacol Res. 2015 Apr;94:9-25. doi: 10.1016/j.phrs.2015.01.003. Epub 2015 Feb 3.
5
Neuroblastoma: molecular pathogenesis and therapy.神经母细胞瘤:分子发病机制与治疗
Annu Rev Med. 2015;66:49-63. doi: 10.1146/annurev-med-011514-023121. Epub 2014 Oct 27.
6
Mechanisms of neuroblastoma regression.神经母细胞瘤消退的机制。
Nat Rev Clin Oncol. 2014 Dec;11(12):704-13. doi: 10.1038/nrclinonc.2014.168. Epub 2014 Oct 21.
7
MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state.MYC 通过 miR-17-92 抑制特定靶基因以维持存活、自主增殖和肿瘤状态。
Cancer Cell. 2014 Aug 11;26(2):262-72. doi: 10.1016/j.ccr.2014.06.014.
8
Roles of raft-anchored adaptor Cbp/PAG1 in spatial regulation of c-Src kinase.脂筏锚定衔接蛋白Cbp/PAG1在c-Src激酶空间调控中的作用。
PLoS One. 2014 Mar 27;9(3):e93470. doi: 10.1371/journal.pone.0093470. eCollection 2014.
9
Src as the link between inflammation and cancer.Src作为炎症与癌症之间的联系。
Front Physiol. 2014 Jan 16;4:416. doi: 10.3389/fphys.2013.00416. eCollection 2013.
10
SRChing for the substrates of Src.搜索 Src 的底物。
Oncogene. 2014 Sep 11;33(37):4537-47. doi: 10.1038/onc.2013.416. Epub 2013 Oct 14.